Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH-Reference-Cited by-同舟云学术

Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH

Published:2019-12 Issue:10 Volume:42 Page:657-676
ISSN:0210-5705
Container-title:Gastroenterología y Hepatología
language:es
Short-container-title:Gastroenterología y Hepatología

Author:

Bataller Ramón,Cabezas Joaquín,Aller Rocío,Ventura-Cots Meritxell,Abad Javier,Albillos Agustín,Altamirano José,Arias-Loste María Teresa,Bañares Rafael,Caballería Juan,Caballería Llorenç,Carrión José Antonio,Diago Moisés,Fernández Rodríguez Conrado,Gallego Rocío,García-Cortes Miren,García-Monzón Carmelo,Genescà Joan,Ginés Pere,Hernandez-Guerra Manuel,Jorquera Francisco,Lligoña Anna,Molina Esther,Pareja María Jesús,Planas Ramón,Tomé Santiago,Salmerón Javier,Romero-Gómez Manuel

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference145 articles.

1. GRADE guidelines: 14. Going from evidence to recommendations: The significance and presentation of recommendations;Andrews;J Clin Epidemiol.,2013

2. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders;Rehm;Lancet (London, England).,2009

3. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease;Zakhari;Hepatology.,2007

4. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69:154-81.

5. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology.,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury;Brain, Behavior, and Immunity;2024-07

2. LIVER FIBROSIS SCREENING INCREASES ALCOHOL ABSTINENCE;JHEP Reports;2024-07

3. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

4. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

5. Challenges and perspectives of liver tissue engineering: From cell therapy to bioprinting;International Journal of Bioprinting;2024-03-29